Biosimilars in rheumatoid arthritis in 2022 – data from the Romanian Registry of Rheumatic Diseases

Objective. The study aimed at determining whether RA patients starting or stopping biosimilars differ in any regard from those starting or stopping originals. Methods. Data on RA patients was obtained from the Romanian Registry of Rheumatic Diseases (RRBR) database between January 1st, 2022, and Dec...

Cijeli opis

Bibliografski detalji

Glavni autori:	Horatiu Popoviciu, Florentin Vreju, Claudiu C. Popescu, Corina Mogosan, Elena Rezus, Simona Rednic, Andra Balanescu, Razvan Adrian Ionescu, Catalin Codreanu
Format:	Artigo
Jezik:	Inglês
Izdano:	Amaltea Medical Publishing House 2023-09-01
Serija:	Romanian Journal of Rheumatology
Teme:	rheumatoid arthritis romanian registry of rheumatic diseases biosimilars
Online pristup:	https://rjr.com.ro/articles/2023.3/RJR_2023_3_Art-06.pdf
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!